LaQuisa Hill

Assistant Professor

Baylor College of Medicine

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

LaQuisa Hill is an Assistant Professor at Baylor College of Medicine in the United States. Her research focuses on cellular immunotherapy, including the study of CAR-T cell therapies and their impact on various hematological malignancies. She has contributed significantly to understanding cytokine release syndrome, therapeutic efficacy in leukemia, and safety outcomes related to immunotherapy. Recent publications highlight her work on novel treatment strategies and their implications for diverse patient populations.

Articles (20)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (12)

Cliona M. Rooney

Baylor College of Medicine

UNITED STATES

View details

sairah ahmed

associate professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Tami John

Associate Professor

Stanford University

UNITED STATES

View details

Mehdi Hamadani

UNITED STATES

View details

Sachin G. Thakkar

Baylor College of Medicine

UNITED STATES

View details

Samer Al Hadidi

Assistant Professor

University of Arkansas for Medical Sciences

UNITED STATES

View details

Gregory Roloff

University of Chicago

UNITED STATES

View details

Norihiro Watanabe

Baylor College of Medicine

UNITED STATES

View details

Nabil Ahmed

Associate Professor

Baylor College of Medicine Department of Pediatrics

UNITED STATES

View details

Carlos Ramos

Professor

Baylor College of Medicine

UNITED STATES

View details

Shoba Navai

Assistant Professor

Baylor College of Medicine Department of Pediatrics

UNITED STATES

View details

Cole Sterling

Assistant Professor

Johns Hopkins University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

LaQuisa Hill

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Cytokine Release Syndrome and Neurotoxicity Following CD19 CAR-T in B-Cell Lymphoma.

Impact of Prior Inotuzumab Ozogamicin Treatment on Brexucabtagene Autoleucel outcomes in Adults with B-cell ALL

Prolonged Cytopenias after Immune Effector Cell Therapy and Lymphodepletion in Patients with Leukemia, Lymphoma, and Solid Tumors

Efficacy of Letermovir for Cytomegalovirus Prophylaxis Following Alemtuzumab T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplant

Outcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALL.

Chimeric antigen receptor-induced antigen loss protects CD5.CART cells from fratricide without compromising on-target cytotoxicity.

Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia

Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomas

An Assessment of CAR-T Cell Therapy Utilization among Racial and Ethnic Minority Patients.

Feasibility and preclinical efficacy of CD7-unedited CD7 CAR T cells for T cell malignancies

Allogeneic haematopoietic cell transplant in patients with relapsed/refractory anaplastic large cell lymphoma

Allogeneic, off-the-shelf, SARS-CoV-2-specific T cells (ALVR109) for the treatment of COVID-19 in high-risk patients

Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs

Rituximab as adjunctive therapy to BEAM conditioning for autologous stem cell transplantation in Hodgkin lymphoma

Beyond CD19 CAR-T cells in lymphoma

COVID-specific T's may offset therapeutically endangered B's

Health disparities experienced by Black and Hispanic Americans with multiple myeloma in the United States: a population-based study.

Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant

Demographic and Clinical Donor Characteristics as Predictors of Total Nucleated Cell Concentrations in Harvested Marrow Products

A phase I trial targeting advanced or metastatic pancreatic cancer using a combination of standard chemotherapy and adoptively transferred nonengineered, multiantigen specific T cells in the first-line setting (TACTOPS).

Collaborators (12)

Cliona M. Rooney

sairah ahmed

Tami John

Mehdi Hamadani

Sachin G. Thakkar

Samer Al Hadidi

Gregory Roloff

Norihiro Watanabe

Nabil Ahmed

Carlos Ramos

Shoba Navai

Cole Sterling

Make your next move.